01 July 2009
By:Peter Houston
Social media is big news. From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minutetominute within huge databases of content that they themselves create.
 |
26 June 2009
Good information management is essential to help pharmaceutical companies efficiently translate large amounts of data into drug market applications, achieve fast time to market and reduce costs and in Europe, many companies and regulatory agencies are actively assessing the potential of the EMEA's XML-based Product Information Management initiative.
|
01 June 2009
Cognizant talks about the importance of master data management and its newly launched solution.
|
01 May 2009
By:Kim Shah
With pressure to cut costs, shorten the pipeline life cycle and maximize return on investment, pharmaceutical manufacturers need tools that help them improve enterprise-wide communications, reach critical decisions faster and produce timely, accurate reports on how compounds are progressing.
|
01 November 2008
By:Alina Halloran
The number of online pharmacies continues to increase exponentially and the global supply chain is at risk of infiltration by counterfeit ingredients. A more proactive approach is needed to ensure consumer safety.
|
01 November 2008
By:Keith Williams, Mark Wright, Jonathan Russell
During the past two decades, regulations have evolved in both Europe and the US to accommodate the technological developments in the pharmaceutical, biotechnology and medical device industries.
|
01 September 2008
By:Venkat Venkatasubramanian, Kenneth R. Morris
The pharmaceutical industry is facing the perfect storm. Increasing healthcare costs, a changing regulatory environment and vigorous global competition coupled with the increasing complexity of small molecule and biotech drugs contributing to expensive discovery processes and clinical trials, as well as the resultant manufacturing challenges, all pose major threats to the industry.
|
01 September 2008
By:Matthew Kopecky
The challenges of ineffective quality monitoring of complaints, investigations and adverse event reporting can lead to patient harm or death, product withdrawal, and negative financial and brand impact to the organization.
|
| 
